Back to search

Article

Sticking to therapy: bioequivalence assessment and adhesion performance of rivastigmine transdermal patch formulations

2026-08-11

Abstract excerpt

<title>Abstract</title> <p> Background: Rivastigmine transdermal drug delivery systems (TDDS) provide smoother plasma concentration profiles and improved tolerability compared with oral formulations. <h4>Methods:</h4> This study aimed to evaluate the bioequivalence, adhesion performance, and safety profile of a branded generic rivastigmine TDDS, Rivazich (13.68 mg, 9.5 mg/24 h) compared with the reference produc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6511b0d-8c87-513e-9224-e307d0307bb1
DOI
10.21203/rs.3.rs-9692373/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sticking to therapy: bioequivalence assessment and adhesion performance of rivastigmine transdermal patch formulationsDOI 10.21203/rs.3.rs-9692373/v1
Select a neighboring publication to make it the new centre.